Borys Michał, Hanych Agata, Czuczwar Mirosław
Second Department of Anesthesia and Intensive Therapy, Medical University of Lublin, 20-059 Lublin, Poland.
Department of Anesthesia and Intensive Therapy, Podkarpackie Center of Lung Disease, 35-241 Rzeszów, Poland.
J Clin Med. 2020 Mar 14;9(3):793. doi: 10.3390/jcm9030793.
Severe postoperative pain affects most patients after thoracotomy and is a risk factor for post-thoracotomy pain syndrome (PTPS). This randomized controlled trial compared preemptively administered ketamine versus continuous paravertebral block (PVB) versus control in patients undergoing posterolateral thoracotomy. The primary outcome was acute pain intensity on the visual analog scale (VAS) on the first postoperative day. Secondary outcomes included morphine consumption, patient satisfaction, and PTPS assessment with Neuropathic Pain Syndrome Inventory (NPSI). Acute pain intensity was significantly lower with PVB compared to other groups at four out of six time points. Patients in the PVB group used significantly less morphine via a patient-controlled analgesia pump than participants in other groups. Moreover, patients were more satisfied with postoperative pain management after PVB. PVB, but not ketamine, decreased PTPS intensity at 1, 3, and 6 months after posterolateral thoracotomy. Acute pain intensity at hour 8 and PTPS intensity at month 3 correlated positively with PTPS at month 6. Bodyweight was negatively associated with chronic pain at month 6. Thus, PVB but not preemptively administered ketamine decreases both acute and chronic pain intensity following posterolateral thoracotomies.
严重的术后疼痛影响大多数开胸手术后的患者,并且是开胸术后疼痛综合征(PTPS)的一个风险因素。这项随机对照试验比较了在接受后外侧开胸手术的患者中,预先给予氯胺酮、持续椎旁阻滞(PVB)与对照组之间的效果。主要结局是术后第一天视觉模拟量表(VAS)上的急性疼痛强度。次要结局包括吗啡用量、患者满意度以及使用神经性疼痛综合征量表(NPSI)进行的PTPS评估。在六个时间点中的四个时间点,与其他组相比,PVB组的急性疼痛强度显著更低。PVB组患者通过患者自控镇痛泵使用的吗啡量明显少于其他组的参与者。此外,患者对PVB术后疼痛管理的满意度更高。后外侧开胸术后1、3和6个月时,PVB可降低PTPS强度,但氯胺酮无此作用。术后8小时的急性疼痛强度和术后3个月的PTPS强度与术后6个月的PTPS呈正相关。体重与术后6个月的慢性疼痛呈负相关。因此,后外侧开胸术后,PVB而非预先给予的氯胺酮可降低急性和慢性疼痛强度。